Development of a new class of liver receptor homolog-1 (LRH-1) agonists by photoredox conjugate addition.
Cornelison, J.L., Cato, M.L., Johnson, A.M., D'Agostino, E.H., Melchers, D., Patel, A.B., Mays, S.G., Houtman, R., Ortlund, E.A., Jui, N.T.(2020) Bioorg Med Chem Lett 30: 127293-127293
- PubMed: 32631515 
- DOI: 10.1016/j.bmcl.2020.127293
- Primary Citation of Related Structures:  
6VIF - PubMed Abstract: 
LRH-1 is a nuclear receptor that regulates lipid metabolism and homeostasis, making it an attractive target for the treatment of diabetes and non-alcoholic fatty liver disease. Building on recent structural information about ligand binding from our labs, we have designed a series of new LRH-1 agonists that further engage LRH-1 through added polar interactions ...